References
- Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997;15:2996–3018.
- Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, . Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010;76:656–65.
- Auperin A, Le PC, Rolland E, Curran WJ, Furuse K, Fournel P, . Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–90.
- Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van ‘t Veer MB, Baaijens MH, de Boer JP, . Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878–86.
- Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, . Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst 2007;99:206–14.
- Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, . Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S77–85.